Tscan Therapeutics Inc · TCRX.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $228.79M − (Liabilities $105.67M + Equity $123.12M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$152.41M
66.6%
-$26.28M
-14.7%
Assets
PPE
$66.45M
29.0%
-$5.15M
-7.2%
Assets
Other
$9.93M
4.3%
-$110.90M
-91.8%
Liabilities + Equity
Short-term debt
$7.17M
3.1%
$2.60M
56.8%
Liabilities + Equity
Long-term debt
$32.53M
14.2%
$462.00K
1.4%
Liabilities + Equity
Other liabilities
$65.97M
28.8%
-$27.54M
-29.5%
Liabilities + Equity
Equity
$123.12M
53.8%
-$117.85M
-48.9%